INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-74 Cr | ₹98 Cr | ₹142 Cr | ₹155 Cr | ₹93 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-74 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
| Mar2021 | ₹93 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-74 Cr | Negative | |
| Mar2024 | ₹98 Cr | -30.78 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | 66.37 | |
| Mar2021 | ₹93 Cr | - | |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,401.2 Cr | 10.3% | 26.6% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 10.3% |
26.6% |
-24.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses